PubMed

Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).

Pan Y, Wang L, Dai JL.

Breast Cancer Res. 2006;8(6):R63.PMID: 17078868 [PubMed - indexed for MEDLINE]Related articlesFree article

Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.

Pan Y, Weinman EJ, Dai JL.

Breast Cancer Res. 2008;10(1):R5. Epub 2008 Jan 11.PMID: 18190691 [PubMed - indexed for MEDLINE]Related articlesFree article

NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.

Dai JL, Wang L, Sahin AA, Broemeling LD, Schutte M, Pan Y.

Oncogene. 2004 Nov 11;23(53):8681-7.PMID: 15467753 [PubMed - indexed for MEDLINE]Related articles

Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.

Bouker KB, Skaar TC, Riggins RB, Harburger DS, Fernandez DR, Zwart A, Wang A, Clarke R.

Carcinogenesis. 2005 Sep;26(9):1527-35. Epub 2005 May 5.PMID: 15878912 [PubMed - indexed for MEDLINE]Related articlesFree article

Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function.

Kreimann EL, Morales FC, de Orbeta-Cruz J, Takahashi Y, Adams H, Liu TJ, McCrea PD, Georgescu MM.

Oncogene. 2007 Aug 9;26(36):5290-9. Epub 2007 Feb 26.PMID: 17325659 [PubMed - indexed for MEDLINE]Related articles

The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.

Cardone RA, Bellizzi A, Busco G, Weinman EJ, Dell'Aquila ME, Casavola V, Azzariti A, Mangia A, Paradiso A, Reshkin SJ.

Mol Biol Cell. 2007 May;18(5):1768-80. Epub 2007 Mar 1.PMID: 17332506 [PubMed - indexed for MEDLINE]Related articlesFree article

NHERF1: molecular brake on the PI3K pathway in breast cancer.

Georgescu MM.

Breast Cancer Res. 2008;10(2):106. Epub 2008 Apr 18.PMID: 18430260 [PubMed - indexed for MEDLINE]Related articlesFree article

TOB suppresses breast cancer tumorigenesis.

O'Malley S, Su H, Zhang T, Ng C, Ge H, Tang CK.

Int J Cancer. 2009 Oct 15;125(8):1805-13.PMID: 19569230 [PubMed - indexed for MEDLINE]Related articles

Roles of NHERF1/EBP50 in cancer.

Georgescu MM, Morales FC, Molina JR, Hayashi Y.

Curr Mol Med. 2008 Sep;8(6):459-68. Review.PMID: 18781953 [PubMed - indexed for MEDLINE]Related articles

Beta-oestradiol rescues DeltaF508CFTR functional expression in human cystic fibrosis airway CFBE41o- cells through the up-regulation of NHERF1.

Fanelli T, Cardone RA, Favia M, Guerra L, Zaccolo M, Monterisi S, De Santis T, Riccardi SM, Reshkin SJ, Casavola V.

Biol Cell. 2008 Jul;100(7):399-412.PMID: 18184109 [PubMed - indexed for MEDLINE]Related articles

Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.

Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ.

Breast Cancer Res Treat. 2009 Feb;113(3):443-56. Epub 2008 Mar 10.PMID: 18327707 [PubMed - indexed for MEDLINE]Related articles

Cell cycle machinery: links with genesis and treatment of breast cancer.

Butt AJ, Caldon CE, McNeil CM, Swarbrick A, Musgrove EA, Sutherland RL.

Adv Exp Med Biol. 2008;630:189-205. Review.PMID: 18637492 [PubMed - indexed for MEDLINE]Related articles

Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells.

Le XF, Arachchige-Don AS, Mao W, Horne MC, Bast RC Jr.

Mol Cancer Ther. 2007 Nov;6(11):2843-57.PMID: 18025271 [PubMed - indexed for MEDLINE]Related articlesFree article

The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers.

Zudaire E, Cuesta N, Murty V, Woodson K, Adams L, Gonzalez N, Martínez A, Narayan G, Kirsch I, Franklin W, Hirsch F, Birrer M, Cuttitta F.

J Clin Invest. 2008 Feb;118(2):640-50.PMID: 18172554 [PubMed - indexed for MEDLINE]Related articlesFree article

Biological role of NHERF1 protein expression in breast cancer.

Mangia A, Chiriatti A, Bellizzi A, Malfettone A, Stea B, Zito FA, Reshkin SJ, Simone G, Paradiso A.

Histopathology. 2009 Nov;55(5):600-8.PMID: 19912366 [PubMed - indexed for MEDLINE]Related articles

The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.

Zia MK, Rmali KA, Watkins G, Mansel RE, Jiang WG.

Int J Mol Med. 2007 Oct;20(4):605-11.PMID: 17786294 [PubMed - indexed for MEDLINE]Related articles

Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product.

Elangovan S, Hsieh TC, Wu JM.

Anticancer Res. 2008 Sep-Oct;28(5A):2641-7.PMID: 19035289 [PubMed - indexed for MEDLINE]Related articles

Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.

Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS.

Breast Cancer Res. 2008;10(2):R22. Epub 2008 Mar 7.PMID: 18328103 [PubMed - indexed for MEDLINE]Related articlesFree article

ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation.

Wang Y, Rathinam R, Walch A, Alahari SK.

J Biol Chem. 2009 Aug 21;284(34):23094-106. Epub 2009 Jun 22.PMID: 19546220 [PubMed - indexed for MEDLINE]Related articles

Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.

Zou Y, Tsai WB, Cheng CJ, Hsu C, Chung YM, Li PC, Lin SH, Hu MC.

Breast Cancer Res. 2008;10(1):R21. Epub 2008 Feb 29.PMID: 18312651 [PubMed - indexed for MEDLINE]Related articlesFree article